AzTrials
AzTrials

Pain ManagementNCT04252378

Ultrasound-guided Deep and Superficial Serratus Anterior Plane Block

A study testing Deep Serratus Anterior Plane Block and Superficial Serratus Anterior Plane Block in people with Pain Management and Thoracotomy, run by Kyungpook National University Hospital at 1 site in South Korea.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study evaluates the difference of deep and superficial serratus anterior plane block on intraoperative opioid consumption, emergence time and hemodynamic stability in patients undergoing video-assisted thoracic surgery. Read more about this study

Who is it for?
Ages 20 to 75 years
Conditions the study is for
Pain Management, Thoracotomy
What is being tested?
Deep Serratus Anterior Plane Block and Superficial Serratus Anterior Plane Block
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
56 participants
Where
1 siteSouth Korea
Study dates
15 Jul 2019to 31 Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • a) American Society of Anesthesiologists (ASA) physical status 1 or 2
  • b) age 20-75 years
  • c) elective three port Video-assisted thoracoscopic surgery (VATS) lobectomy.

Who cannot join

  • a) a history of drug allergy for opioids or local anesthetics
  • b) local infection at the injection site and systemic infection
  • c) coagulopathy
  • d) difficulty in understanding the study protocol
  • e) refusal to participate

Trial locations and contacts

1 site in 1 country.

South Korea1 site, 1 recruiting
  • Kyungpook national university hospital

    Daegu, 700-412

    Jimin Heo, 82-53-420-5430, knuhmrc@knu.ac.kr

    Recruiting

Other trials in South Korea

About this study

Official title: Comparison of Intraoperative Opioid Consumption, Emergence Time and Hemodynamic Stability Between Ultrasound-guided Deep and Superficial Serratus Anterior Plane Block During Video-assisted Thoracoscopic Lobectomy

This study evaluates the difference of deep and superficial serratus anterior plane block on intraoperative opioid consumption, emergence time and hemodynamic stability in patients undergoing video-assisted thoracic surgery.

Read the detailed description

Thoracotomy is known as one of the most painful surgery. Thus, there is a development to reduce surgical stress in terms of operation technique, which is video-assisted thoracoscopic surgery. Although it has reduced postoperative pain and complications compared with thoracotomy, VATS is still quite painful operation. Serratus plane block is a novel technique which provide analgesic effect for lateral chest wall by blocking lateral branch of intercostal nerve. Two methods were proposed to target the top and bottom of the serratus anterior muscle. However, the difference of deep and superficial serratus anterior plane block during intraoperative period has not yet been studied.

In this study, therefore, the investigators decided to assess the difference of deep and superficial serratus anterior plane block on intraoperative opioid consumption, emergence time and hemodynamic stability in patients undergoing video-assisted thoracic surgery.

Being tested
Deep Serratus Anterior Plane Block, Superficial Serratus Anterior Plane Block
Medical subject headings
Agnosia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Deep Serratus Anterior Plane BlockProcedure or surgery

    Deep Serratus Anterior Plane Block was performed just before the start of surgery after anesthetic induction through ultrasound-guidance.

  • Superficial Serratus Anterior Plane BlockProcedure or surgery

    Superficial Serratus Anterior Plane Block was performed just before the start of surgery after anesthetic induction through ultrasound-guidance.

Study groups in NCT04252378
Study groupRoleWhat they receive
Deep Serratus Anterior Plane BlockExperimentalDeep Serratus Anterior Plane Block was performed just before the start of surgery after anesthetic induction through ultrasound-guidance. 20ml of 0.375% ropivacaine was slowly injected between the fascia of serratus anterior and external intercostal muscle near 5th rib.
Receives: Procedure: Deep Serratus Anterior Plane Block
Superficial Serratus Anterior Plane BlockActive comparatorSuperficial Serratus Anterior Plane Block was performed just before the start of surgery after anesthetic induction through ultrasound-guidance. 20ml of 0.375% ropivacaine was slowly injected between the fascia of serratus anterior and latissimus dorsi near 5th rib.
Receives: Procedure: Superficial Serratus Anterior Plane Block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intraoperative remifentanil consumption

    Intraoperative remifentanil consumption will be checked.

    Measured: through study completion, an average of 1 year

Secondary outcomes (5)
  1. Emergence time

    Emergence time is duration between the end of surgery and extubation. Emergence time will be checked.

    Measured: through study completion, an average of 1 year

  2. Systolic blood pressure

    Systolic blood pressure (mmHg) will be checked

    Measured: through study completion, an average of 1 year

  3. Heart rate (HR) Heart rate

    Heart rate (beats per minute) will be checked

    Measured: through study completion, an average of 1 year

  4. Dose of rescue drugs used to control blood pressure and HR

    Dose of rescue drugs used to control blood pressure and HR will be checked

    Measured: through study completion, an average of 1 year

  5. Postoperative pain: numeric rating scale

    Postoperative pain will be evaluated using a numeric rating scale (0 being no pain, 10 being worst pain imaginable)

    Measured: 30 minutes later operation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Feb 2020
  2. Study start15 Jul 2019
  3. Primary completion29 Feb 2020 (estimated)
  4. Study completion31 Mar 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
56 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04252378
Sponsor's protocol ID
2019-05-003-001
Status last verified
Feb 2020
First submitted
31 Jan 2020
Last updated
5 Feb 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Deep Serratus Anterior Plane Block and Superficial Serratus Anterior Plane Block in people with Pain Management and Thoracotomy, run by Kyungpook National University Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jimin Heo (+82-53-420-5430, knuhmrc@knu.ac.kr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intraoperative remifentanil consumption (time frame: through study completion, an average of 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Feb 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in